DE60235576D1 - Diagnostikum für die frühe phase von morbus alzheimer - Google Patents

Diagnostikum für die frühe phase von morbus alzheimer

Info

Publication number
DE60235576D1
DE60235576D1 DE60235576T DE60235576T DE60235576D1 DE 60235576 D1 DE60235576 D1 DE 60235576D1 DE 60235576 T DE60235576 T DE 60235576T DE 60235576 T DE60235576 T DE 60235576T DE 60235576 D1 DE60235576 D1 DE 60235576D1
Authority
DE
Germany
Prior art keywords
diagnostic
early phase
morbus alzheimer
alzheimer
morbus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235576T
Other languages
English (en)
Inventor
Xianlin Han
David M Holtzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of DE60235576D1 publication Critical patent/DE60235576D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60235576T 2001-12-10 2002-12-10 Diagnostikum für die frühe phase von morbus alzheimer Expired - Lifetime DE60235576D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33918801P 2001-12-10 2001-12-10
PCT/US2002/039567 WO2003050528A1 (en) 2001-12-10 2002-12-10 Diagnostic for early stage alzheimer's disease

Publications (1)

Publication Number Publication Date
DE60235576D1 true DE60235576D1 (de) 2010-04-15

Family

ID=23327889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235576T Expired - Lifetime DE60235576D1 (de) 2001-12-10 2002-12-10 Diagnostikum für die frühe phase von morbus alzheimer

Country Status (7)

Country Link
US (1) US7015044B2 (de)
EP (1) EP1461611B1 (de)
AT (1) ATE459877T1 (de)
AU (1) AU2002366555A1 (de)
CA (1) CA2469486A1 (de)
DE (1) DE60235576D1 (de)
WO (1) WO2003050528A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108051A2 (en) * 2005-04-05 2006-10-12 Neurodx, Llc Compositions and methods relating to alzheimer's disease
US8026099B2 (en) * 2007-07-26 2011-09-27 Washington University Lipid profile as a biomarker for early detection of neurological disorders
FI20115576A0 (fi) 2011-06-10 2011-06-10 Teknologian Tutkimuskeskus Vtt Oy Menetelmä Alzheimerin taudin diagnoimiseksi
MX2015007494A (es) * 2012-12-11 2015-12-15 Centogene Ag Metodo para diagnosticar leucodistrofia metacromatica.
CN112834653B (zh) * 2021-04-09 2023-02-28 宝枫生物科技（北京）有限公司 用于诊断脑白质病变的生物标志物f3及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197833B1 (en) * 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
US6159476A (en) * 1999-01-11 2000-12-12 Herbaceuticals Herbal supplement for increased muscle strength and endurance for athletes
WO2001049875A1 (en) 1999-12-30 2001-07-12 Washington University Predictive diagnostic for alzheimer"s disease
US6426097B2 (en) * 2000-01-28 2002-07-30 Herbaceuticals Inc. Herbal supplement for cognitive related impairment due to estrogen loss

Also Published As

Publication number Publication date
WO2003050528A1 (en) 2003-06-19
EP1461611A1 (de) 2004-09-29
ATE459877T1 (de) 2010-03-15
EP1461611A4 (de) 2005-01-26
AU2002366555A1 (en) 2003-06-23
US20030180959A1 (en) 2003-09-25
EP1461611B1 (de) 2010-03-03
US7015044B2 (en) 2006-03-21
CA2469486A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
DE602004011931D1 (de) Gleichenden diagnose von alzheimer
ATE314354T1 (de) Radiopharmazeutika für die diagnose von alzheimer
ATE283485T1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
EP2298361A3 (de) Okulare Diagnose der Alzheimer-Krankheit
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
DE69333167D1 (de) Diagnostischer test spezifisch für die latente matrix metalloproteinase no. 9
DE60322848D1 (de) System für kontinuierliche leistungstests
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
ATE451477T1 (de) Diagnose und überwachung von hepatozellulärem karzinom
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
DE60239377D1 (de) Träger für elektrophotographische Entwickler und Entwickler die den Träger enthalten
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
ATE459877T1 (de) Diagnostikum für die frühe phase von morbus alzheimer
BR0313194A (pt) Método para diagnose de esclerose múltipla
WO2004107958A3 (en) Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
EA200200435A1 (ru) Анализ лептина
DK0720745T3 (da) Fremgangsmåde til kvantificering af ekstracellulært BPI i legemsvæsker
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
BR0110603A (pt) Couro natural revestido com poliuretano e método de preparação de couro natural revestido
PT1297342E (pt) Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii
WO2003054547A3 (en) Diagnosis of dementia utilizing thrombospondin
WO1999002193A3 (de) Perfluoralkylgruppenhaltige trijodaromaten, verfahren zu deren herstellung und deren verwendung als kontrastmittel
WO2004098391A3 (en) Methods for detecting parvovirous infections
FI951778A0 (fi) Menetelmä allergian toteamiseksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition